SUBSCRIBE
SUBSCRIBE
News   Deals

CombinatoRx, Incorporated Cuts IPO Price To $7-$9 Per Share

November 9, 2005 | 
1 min read

WASHINGTON, Nov 9 (Reuters) - Biopharmaceutical company CombinatoRx Inc. cut on Wednesday the expected price of the shares in its initial public offering to $7 to $9 per share from $10 to $12 per share.

IPO
MORE ON THIS TOPIC
Handshake gesture contemporary collage art. Celebrating success, congratulating for financial and business partnership, job contract deal, mutual friendship and respect. Abstract illustration isolated.
Alzheimer’s disease
GSK Strikes Third Agreement This Week, Leans Further Into Neuro
December 5, 2024
 · 
2 min read
 · 
Tristan Manalac
GSK's headquarters office building in Poznan, Poland
ADCs
GSK Turns Back to China in Another Potential $1B+ ADC Deal
December 4, 2024
 · 
1 min read
 · 
Kate Goodwin
Crowdfunding concept with money icon and human hands in retro 80s collage mixed media vector illustration. Idea for financing business project, funding, philanthropy, cooperation, bank credit and startup development.
Series A
Obesity-Focused Antag Debuts With $84M and Backing From Novo Holdings
December 4, 2024
 · 
2 min read
 · 
Heather McKenzie
Podcast
Biopharma’s Shopping Spree, Applied Crashes on Rejection, Skysona’s Safety Concerns, More
December 4, 2024
 · 
1 min read
 · 
Heather McKenzie